Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) EPS (Weighted Average and Diluted) (2021 - 2025)

Coeptis Therapeutics Holdings has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at -$0.38 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.38 for Q4 2025, up 92.84% from a year ago — trailing twelve months through Dec 2025 was -$0.38 (up 93.11% YoY), and the annual figure for FY2025 was -$2.81, up 49.46%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.38 at Coeptis Therapeutics Holdings, up from -$0.75 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for COEPW hit a ceiling of $0.45 in Q3 2021 and a floor of -$15.8 in Q4 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.24 (2023), compared with a mean of -$1.5.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 7574.94% in 2023 and later skyrocketed 92.84% in 2025.
  • Coeptis Therapeutics Holdings' EPS (Weighted Average and Diluted) stood at -$1.25 in 2021, then skyrocketed by 83.54% to -$0.21 in 2022, then crashed by 7574.94% to -$15.8 in 2023, then surged by 66.14% to -$5.35 in 2024, then skyrocketed by 92.84% to -$0.38 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.38 (Q4 2025), -$0.75 (Q3 2025), and -$1.28 (Q2 2025) per Business Quant data.